rs1556888586
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate
The NM_006306.4(SMC1A):c.2446C>T(p.Arg816Cys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R816H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006306.4 missense
Scores
Clinical Significance
Conservation
Publications
- Cornelia de Lange syndrome 2Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- developmental and epileptic encephalopathy, 85, with or without midline brain defectsInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cornelia de Lange syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006306.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMC1A | NM_006306.4 | MANE Select | c.2446C>T | p.Arg816Cys | missense | Exon 16 of 25 | NP_006297.2 | ||
| SMC1A | NM_001281463.1 | c.2380C>T | p.Arg794Cys | missense | Exon 17 of 26 | NP_001268392.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMC1A | ENST00000322213.9 | TSL:1 MANE Select | c.2446C>T | p.Arg816Cys | missense | Exon 16 of 25 | ENSP00000323421.3 | ||
| SMC1A | ENST00000375340.10 | TSL:1 | c.2380C>T | p.Arg794Cys | missense | Exon 17 of 26 | ENSP00000364489.7 | ||
| SMC1A | ENST00000675504.1 | c.2380C>T | p.Arg794Cys | missense | Exon 16 of 25 | ENSP00000502524.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Congenital muscular hypertrophy-cerebral syndrome Uncertain:1
In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This sequence change replaces arginine with cysteine at codon 816 of the SMC1A protein (p.Arg816Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a SMC1A-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0").
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at